Early Graft Failure

  • Avery L. Smith
  • Srinath Chinnakotla
  • James F. Trotter


The increasing organ donor shortage and widening indications for transplants has forced the use of liver allografts with expanded criteria that are allocated to sicker and more decompensated recipients, allowing a greater volume of transplants. Furthermore, advances in surgical technique have allowed the use of partial liver grafts both split and living donor in order to increase to the donor pool. Consequently, graft dysfunction, graft failure, and small for size syndrome (SFSS) have become more important than ever. Clinically, post-liver transplant graft failure is a continuum ranging from an ambiguous and easily reversible graft dysfunction to a complete absence of function called primary non-function. The incidence of graft dysfunction varies from 13 to 27% and the incidence of primary non-function affects 4 to 7% of deceased donor liver grafts [1, 2]. With living donor transplantation, cold and warm ischemia times are minimal and donor quality typically excellent...


Liver function Acidosis Liver blood flow Small for size syndrome Ischemia-reperfusion injury Early allograft dysfunction 


  1. 1.
    Maring JK, Klompmaker IJ, Zwaveling JH, Kranenburg K, Ten Vergert EM, Slooff MJ. Poor initial graft function after orthotopic liver transplantation: can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations. Clin Transpl. 1997;11:373–9.Google Scholar
  2. 2.
    Deschenes M. Early allograft dysfunction: causes, recognition, and management. Liver Transpl. 2013;19S:SS6–8.CrossRefGoogle Scholar
  3. 3.
    Olthoff KM, Merion RM, Ghobrial RM, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients. Ann Surg. 2005;242:314–25.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Roloff JS. Disseminated intravascular coagulation and other acquired bleeding disorders. In: Levin DL, Morris FC, editors. Essentials of pediatric intensive care. St. Louis: Quality Medical Publishing; 1990.Google Scholar
  5. 5.
    Rosen HR, Martin P, Goss J, et al. Significance of early aminotransferase elevation after liver transplantation. Transplantation. 1998;65:68–72.CrossRefGoogle Scholar
  6. 6.
    Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and an analysis of risk factors. Liver Transpl. 2010;16:943–9.CrossRefGoogle Scholar
  7. 7.
    Pareja E, Cortes M, Hervás D, et al. A score model for the continuous grading of early allograft dysfunction severity. Liver Transpl. 2015;21:38–46.CrossRefGoogle Scholar
  8. 8.
    Wadei HM, Lee DD, Croome KP, et al. Early allograft dysfunction after liver transplantation is associated with short-and long-term kidney function impairment. Am J Transplant. 2016;16:850–9.CrossRefGoogle Scholar
  9. 9.
    Uemura T, Randall HB, Sanchez EQ, Ikegami T, Narasimhan G, McKenna GJ, et al. Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl. 2007;13:227–33.CrossRefGoogle Scholar
  10. 10.
    Henley KS, Lucey MR, Normolle DP, et al. A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology. 1995;21:366–72.PubMedGoogle Scholar
  11. 11.
    Oldhafer KJ, Bornscheuer A, Fruhauf NR, et al. Rescue hepatectomy for initial graft non-function after liver transplantation. Transplantation. 1999;67:1024–8.CrossRefGoogle Scholar
  12. 12.
    Demetris AJ, Kelly DM, Eghtesad B, et al. Pathophysiologic observations and histopathologic recognition of the portal hyper perfusion or small for size syndrome. Am J Surg Pathol. 2006;30:986–93.CrossRefGoogle Scholar
  13. 13.
    Dahm F, Georgiev P, Clavien P. Small for size syndrome after partial liver transplantation: definition, mechanisms, of disease and clinical implications. Am J Transplant. 2005;5:2605–10.CrossRefGoogle Scholar
  14. 14.
    Dutkowski P, Linecker M, DeOliveira ML, et al. Challenges to liver transplantation and strategies to improve outcomes. Gastroenterology. 2015;148:307–23.CrossRefGoogle Scholar
  15. 15.
    Humar A, Beissel J, Crotteau S, et al. Delayed splenic artery occlusion for treatment of established small for size syndrome after partial liver transplantation. Liver Transpl. 2009;15:163–8.CrossRefGoogle Scholar
  16. 16.
    Lee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant. 2015;15:17–38.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Avery L. Smith
    • 1
  • Srinath Chinnakotla
    • 2
  • James F. Trotter
    • 1
  1. 1.Baylor University Medical CenterDallasUSA
  2. 2.Department of SurgeryUniversity of MinnesotaMinneapolisUSA

Personalised recommendations